Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

PRIMARY MALIGNANT MELANOMA OF THE URINARY BLADDER: CASE REPORT.

Kirigin M, Lež C, Šarčević B, Šoipi Š, Jaić G, Ulamec M, Krušlin B.

Acta Clin Croat. 2019 Mar;58(1):180-182. doi: 10.20471/acc.2019.58.01.23.

2.

Inter-laboratory comparison of Ki-67 proliferating index detected by visual assessment and automated digital image analysis.

Tomić S, Mrklić I, Razumović JJ, Jonjić N, Šarčević B, Blažičević V, Jurković I, Vrbičić B, Lisica Šikic N, Peteh LL, Lončarić ČT, Vučić M, Gašparov S, Švagelj D, Radiković S, Mahovne I.

Breast Dis. 2019;38(2):73-79. doi: 10.3233/BD-180341.

PMID:
30958325
3.

Critical evaluation of the use of total reflection X-ray fluorescence spectrometry for the analysis of whole blood samples: application to patients with thyroid gland diseases.

Marguí E, Jablan J, Gerić M, Inić S, Domijan AM, Janušić R, Šarčević B, Queralt I, Garaj-Vrhovac V.

Anal Bioanal Chem. 2019 Mar;411(8):1659-1670. doi: 10.1007/s00216-019-01618-3. Epub 2019 Feb 1.

PMID:
30707263
4.

Possible predictive role of cancer/testis antigens in breast ductal carcinoma in situ.

Roguljic A, Spagnoli G, Juretic A, Sarcevic B, Banovic M, Beketic Oreskovic L.

Oncol Lett. 2018 Dec;16(6):7245-7255. doi: 10.3892/ol.2018.9544. Epub 2018 Oct 3.

5.

Phosphorylation of Drosophila Brahma on CDK-phosphorylation sites is important for cell cycle regulation and differentiation.

Roesley SNA, La Marca JE, Deans AJ, Mckenzie L, Suryadinata R, Burke P, Portela M, Wang H, Bernard O, Sarcevic B, Richardson HE.

Cell Cycle. 2018;17(13):1559-1578. doi: 10.1080/15384101.2018.1493414. Epub 2018 Jul 14.

6.

Tuberculosis of the Oral Cavity Misdiagnosed as Precancerous Lesion.

Vučičević Boras V, Gabrić D, Smiljanić Tomičević L, Seiwerth S, Gršić K, Šarčević B, Lončar Brzak B, Marunica E, Glavina A.

Acta Stomatol Croat. 2017 Dec;51(4):326-331. doi: 10.15644/asc51/4/7.

7.

Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients.

Ozretic P, Alvir I, Sarcevic B, Vujaskovic Z, Rendic-Miocevic Z, Roguljic A, Beketic-Oreskovic L.

Int J Biol Markers. 2018 Jan;33(1):109-115. doi: 10.5301/ijbm.5000291.

PMID:
28777433
8.

Expression of nm23-H1 and COX-2 in thyroid papillary carcinoma and microcarcinoma.

Perisa MM, Sarcevic B, Troselj KG, Grsic K, Sitic S, Seiwerth S.

Oncol Lett. 2017 May;13(5):3547-3555. doi: 10.3892/ol.2017.5876. Epub 2017 Mar 17.

9.

The prognostic significance of estrogen receptor β in head and neck squamous cell carcinoma.

Grsic K, Opacic IL, Sitic S, Milkovic Perisa M, Suton P, Sarcevic B.

Oncol Lett. 2016 Nov;12(5):3861-3865. Epub 2016 Sep 15.

10.

Cytogenetic status and oxidative stress parameters in patients with thyroid diseases.

Gerić M, Domijan AM, Gluščić V, Janušić R, Šarčević B, Garaj-Vrhovac V.

Mutat Res. 2016 Nov 1;810:22-29. doi: 10.1016/j.mrgentox.2016.09.010. Epub 2016 Sep 29.

PMID:
27776688
11.

INTERLABORATORY CONCORDANCE IN HER-2 POSITIVE BREAST CANCER.

Jonjić N, Mustać E, Tomić S, Razumović JJ, Sarcević B, Blazicević V, Labinac LP, Svagelj D, Kopjar A, Sikić NL, Vrbicić B, Borić I.

Acta Clin Croat. 2015 Dec;54(4):479-85.

PMID:
27017723
12.

Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.

Roesley SN, Suryadinata R, Morrish E, Tan AR, Issa SM, Oakhill JS, Bernard O, Welch DR, Šarčević B.

Cell Cycle. 2016;15(1):137-51. doi: 10.1080/15384101.2015.1121328.

13.

E2 superfamily of ubiquitin-conjugating enzymes: constitutively active or activated through phosphorylation in the catalytic cleft.

Valimberti I, Tiberti M, Lambrughi M, Sarcevic B, Papaleo E.

Sci Rep. 2015 Oct 14;5:14849. doi: 10.1038/srep14849.

14.

Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions.

Kővári B, Szász AM, Kulka J, Marušić Z, Šarčević B, Tiszlavicz L, Cserni G.

Pathobiology. 2015 Sep;82(3-4):166-71. doi: 10.1159/000375127. Epub 2015 Aug 31.

15.

[Clinical recommendations for diagnosis, treatment and monitoring of patients with cancer of unknown primary site].

Bišof V, Juretić A, Trivanović D, Dintinjana RD, Sarçević B, Jakić-Razumović J, Ban M, Bošković L, Mise B-, Bura M, Stančić-Rokotov D.

Lijec Vjesn. 2015 Mar-Apr;137(3-4):65-9. Croatian.

PMID:
26065281
16.

A case-control study of genotoxicity endpoints in patients with papillary thyroid cancer.

Gerić M, Janušić R, Šarčević B, Garaj-Vrhovac V.

Mutat Res Genet Toxicol Environ Mutagen. 2015 Jun;784-785:47-50. doi: 10.1016/j.mrgentox.2015.05.006. Epub 2015 May 14.

PMID:
26046977
17.

IQGAP1 is associated with nuclear envelope reformation and completion of abscission.

Lian AT, Hains PG, Sarcevic B, Robinson PJ, Chircop M.

Cell Cycle. 2015;14(13):2058-74. doi: 10.1080/15384101.2015.1044168. Epub 2015 Apr 30.

18.

Obstructive Jaundice as an Uncommon Manifestation of Metastatic Breast Cancer.

Budimir I, Sabol Pusic M, Nikolic M, Dorosulic Z, Ljubicic N, Stajduhar E, Mise I, Vazdar L, Sarcevic B.

World J Oncol. 2015 Feb;6(1):297-300. doi: 10.14740/wjon762w. Epub 2015 Feb 14.

19.

Mechanisms of generating polyubiquitin chains of different topology.

Suryadinata R, Roesley SN, Yang G, Sarčević B.

Cells. 2014 Jul 1;3(3):674-89. doi: 10.3390/cells3030674.

20.

The level of serum pro-matrix metalloproteinase-2 as a prognostic factor in patients with invasive ductal breast cancer.

Vucemilo T, Skoko M, Sarcević B, Puljiz M, Alvir I, Turudić TP, Mihaljević I.

Coll Antropol. 2014 Mar;38(1):135-40.

PMID:
24851607
21.

Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.

Hugo HJ, Pereira L, Suryadinata R, Drabsch Y, Gonda TJ, Gunasinghe NP, Pinto C, Soo ET, van Denderen BJ, Hill P, Ramsay RG, Sarcevic B, Newgreen DF, Thompson EW.

Breast Cancer Res. 2013 Nov 27;15(6):R113. doi: 10.1186/bcr3580.

22.

LIMK2 mediates resistance to chemotherapeutic drugs in neuroblastoma cells through regulation of drug-induced cell cycle arrest.

Gamell C, Schofield AV, Suryadinata R, Sarcevic B, Bernard O.

PLoS One. 2013 Aug 21;8(8):e72850. doi: 10.1371/journal.pone.0072850. eCollection 2013.

23.

Molecular and structural insight into lysine selection on substrate and ubiquitin lysine 48 by the ubiquitin-conjugating enzyme Cdc34.

Suryadinata R, Holien JK, Yang G, Parker MW, Papaleo E, Šarčević B.

Cell Cycle. 2013 Jun 1;12(11):1732-44. doi: 10.4161/cc.24818. Epub 2013 May 8.

24.

Morphometry in differential diagnosis of pathologically altered parathyroid glands: adenoma and hyperplasia.

Fustar-Preradović L, Sarcević B, Danić D.

Coll Antropol. 2012 Nov;36 Suppl 2:47-51.

PMID:
23397754
25.

Tubulin polymerization promoting protein 1 (Tppp1) phosphorylation by Rho-associated coiled-coil kinase (rock) and cyclin-dependent kinase 1 (Cdk1) inhibits microtubule dynamics to increase cell proliferation.

Schofield AV, Gamell C, Suryadinata R, Sarcevic B, Bernard O.

J Biol Chem. 2013 Mar 15;288(11):7907-17. doi: 10.1074/jbc.M112.441048. Epub 2013 Jan 25.

26.

[Clinical guidelines for diagnosis, treatment and monitoring of patients with non-invasive breast cancer].

Brnijć Z, Brkljacić B, Drinković I, Jakić-Razumović J, Kardum-Skelin I, Krajina Z, Margaritoni M, Strnad M, Sarcević B, Tomić S, Zic R; Croatian Senology Society HLZ.

Lijec Vjesn. 2012 Sep-Oct;134(9-10):259-65. Croatian.

PMID:
23297509
27.

Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes.

Sadowski M, Suryadinata R, Tan AR, Roesley SN, Sarcevic B.

IUBMB Life. 2012 Feb;64(2):136-42. doi: 10.1002/iub.589. Epub 2011 Nov 30. Review.

28.

Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.

Beketic-Oreskovic L, Ozretic P, Rabbani ZN, Jackson IL, Sarcevic B, Levanat S, Maric P, Babic I, Vujaskovic Z.

Pathol Oncol Res. 2011 Sep;17(3):593-603. doi: 10.1007/s12253-010-9355-6. Epub 2011 Jan 20.

PMID:
21249485
29.

Phosphorylation of dynamin II at serine-764 is associated with cytokinesis.

Chircop M, Sarcevic B, Larsen MR, Malladi CS, Chau N, Zavortink M, Smith CM, Quan A, Anggono V, Hains PG, Graham ME, Robinson PJ.

Biochim Biophys Acta. 2011 Oct;1813(10):1689-99. doi: 10.1016/j.bbamcr.2010.12.018. Epub 2010 Dec 29.

30.

Cyclin-dependent kinase-mediated phosphorylation of RBP1 and pRb promotes their dissociation to mediate release of the SAP30·mSin3·HDAC transcriptional repressor complex.

Suryadinata R, Sadowski M, Steel R, Sarcevic B.

J Biol Chem. 2011 Feb 18;286(7):5108-18. doi: 10.1074/jbc.M110.198473. Epub 2010 Dec 9.

31.

Significance of epidermal growth factor receptor expression in breast cancer.

Badovinac-Crnjevic T, Jakic-Razumovic J, Podolski P, Pleština S, Sarčević B, Munjas R, Vrbanec D.

Med Oncol. 2011 Dec;28 Suppl 1:S121-8. doi: 10.1007/s12032-010-9738-2. Epub 2010 Nov 23.

PMID:
21104342
33.

Fine needle aspiration cytology in diagnosing rare breast carcinoma--two case reports.

Ramljak V, Sarcević B, Vrdoljak DV, Kelcec IB, Agai M, Ostović KT.

Coll Antropol. 2010 Mar;34(1):201-5.

PMID:
20432752
34.

Geminin and Brahma act antagonistically to regulate EGFR-Ras-MAPK signaling in Drosophila.

Herr A, Mckenzie L, Suryadinata R, Sadowski M, Parsons LM, Sarcevic B, Richardson HE.

Dev Biol. 2010 Aug 1;344(1):36-51. doi: 10.1016/j.ydbio.2010.04.006. Epub 2010 Apr 21.

35.

Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates.

Suryadinata R, Sadowski M, Sarcevic B.

Biosci Rep. 2010 Mar 17;30(4):243-55. doi: 10.1042/BSR20090171. Review.

PMID:
20337599
36.

Molecular basis for lysine specificity in the yeast ubiquitin-conjugating enzyme Cdc34.

Sadowski M, Suryadinata R, Lai X, Heierhorst J, Sarcevic B.

Mol Cell Biol. 2010 May;30(10):2316-29. doi: 10.1128/MCB.01094-09. Epub 2010 Mar 1.

37.

Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer.

Pastorcic-Grgic M, Sarcevic B, Dosen D, Juretic A, Spagnoli GC, Grgic M.

Head Neck. 2010 Sep;32(9):1178-84. doi: 10.1002/hed.21314.

PMID:
20029985
38.

[Apoptosis in tumors].

Sarcević B.

Acta Med Croatica. 2009 Oct;63 Suppl 2:43-7. Review. Croatian.

PMID:
19999546
39.

[Histopathologic diagnosis of luminal and basal type breast cancer].

Sarcević B.

Acta Med Croatica. 2008 Oct;62(4):427-30. Croatian.

PMID:
19205420
40.
41.

The phosphorylation of p25/TPPP by LIM kinase 1 inhibits its ability to assemble microtubules.

Acevedo K, Li R, Soo P, Suryadinata R, Sarcevic B, Valova VA, Graham ME, Robinson PJ, Bernard O.

Exp Cell Res. 2007 Dec 10;313(20):4091-106.

PMID:
18028908
42.
43.

Expression of MAGE tumor-associated antigen in thyroid carcinomas.

Milkovic M, Sarcevic B, Glavan E.

Endocr Pathol. 2006 Spring;17(1):45-52.

PMID:
16760579
44.

Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.

Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.

Croat Med J. 2006 Feb;47(1):32-41.

45.

Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis.

Fabbro M, Zhou BB, Takahashi M, Sarcevic B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y, Khanna KK.

Dev Cell. 2005 Oct;9(4):477-88.

46.

Analysis of metastatic involvement of interpectoral (Rotter's) lymph nodes related to tumor location, size, grade and hormone receptor status in breast cancer.

Vrdoljak DV, Ramljak V, Muzina D, Sarceviç B, Knezević F, Juzbasić S.

Tumori. 2005 Mar-Apr;91(2):177-81.

PMID:
15948548
47.

Distinct requirements for the Sprouty domain for functional activity of Spred proteins.

King JA, Straffon AF, D'Abaco GM, Poon CL, I ST, Smith CM, Buchert M, Corcoran NM, Hall NE, Callus BA, Sarcevic B, Martin D, Lock P, Hovens CM.

Biochem J. 2005 Jun 1;388(Pt 2):445-54.

48.

Interplay between components of a novel LIM kinase-slingshot phosphatase complex regulates cofilin.

Soosairajah J, Maiti S, Wiggan O, Sarmiere P, Moussi N, Sarcevic B, Sampath R, Bamburg JR, Bernard O.

EMBO J. 2005 Feb 9;24(3):473-86. Epub 2005 Jan 20.

49.

Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.

Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ, Sarcevic B.

Mol Cell Endocrinol. 2005 Jan 14;229(1-2):161-73.

PMID:
15607540
50.

The T-cell protein tyrosine phosphatase is phosphorylated on Ser-304 by cyclin-dependent protein kinases in mitosis.

Bukczynska P, Klingler-Hoffmann M, Mitchelhill KI, Lam MH, Ciccomancini M, Tonks NK, Sarcevic B, Kemp BE, Tiganis T.

Biochem J. 2004 Jun 15;380(Pt 3):939-49.

Supplemental Content

Loading ...
Support Center